\
&
Contact us
\
&
Contact us
Published on | 1 year ago
ProgrammesA new video series is available now @ the NCP Flanders website through the following link: European Partnerships under Horizon Europe
NCP Flanders, together with VLAIO and FWO, want to give you an overview of the complex landscape and constructions of EU-Partnerships.
We guide you through the different types of partnerships and briefly indicate the modalities and contacts for furhter information.
The slides from the presentations are also available under each section.
We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).
Stay informed about what matters to you.
By signing up, you can opt in for e-mail notifications and get access to
a personalised dashboard that groups all news updates and event announcements in your domain(s).
Only for stakeholders located in Flanders
Security Digital, Industry & Space Cybersecurity
On 28 January 2026, the SECURE project has launched a first round of financial support measures to help small businesses achieve compliance with new cybersecurity requirements for their hardware and software products. This will allow micro, small and medium enterprises (MSMEs) to request co-funding to strengthen the cybersecurity of their hardware... read more
Climate, Energy, Mobility Horizon Europe HorizonEU L+F
The well-known Excel template used to prepare and submit the detailed budget in lump sum proposals will be successively replaced in the course of 2026 by an online detailed budget table, integrated directly in the Part A application forms. The new format is currently used in 9 topics in Cluster 5 (see list below). When preparing the project proposa... read more
The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.
